Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on May 2, 2013, to report its financial results for the first quarter ended March 31, 2013. The filing primarily serves to attach the press release detailing these results, which provides both GAAP and non-GAAP financial information. Investors should note that while non-GAAP measures are presented for enhanced understanding and internal management use, they are not prepared under comprehensive accounting rules and should be considered supplementary to the official GAAP financial statements. The press release, available as Exhibit 99.1, contains the detailed financial performance for the quarter. Investors are encouraged to review this exhibit for a complete understanding of Gilead's financial condition and operational results during the period, including the reconciliation between GAAP and non-GAAP figures provided within the press release itself.
Key Highlights
- 1Gilead Sciences announced its first-quarter 2013 financial results via an 8-K filing on May 2, 2013.
- 2The filing includes a press release (Exhibit 99.1) detailing the financial performance for the quarter ended March 31, 2013.
- 3Both Generally Accepted Accounting Principles (GAAP) and non-GAAP financial measures are presented in the press release.
- 4Management utilizes non-GAAP financial information internally for operational and planning purposes.
- 5Investors are advised that non-GAAP information should supplement, not replace, the understanding of GAAP financial results.
- 6A reconciliation between GAAP and non-GAAP financial figures is provided within the press release.
- 7The information furnished in this 8-K and its exhibits is not considered 'filed' for certain regulatory purposes under the Securities Exchange Act of 1934.